The utility of ductal lavage in breast cancer detection and risk assessment

Autor Domchek, Susan M
Vydáno 2002

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers

Autor Rebbeck, Timothy R, Domchek, Susan M
Vydáno 2008

Breast cancer gene variants: separating the harmful from the harmless

Autor Domchek, Susan M., Greenberg, Roger A.
Vydáno 2009

Breast cancer in young women

Autor Gabriel, Courtney A, Domchek, Susan M
Vydáno 2010

Update on Genetic Testing in Gynecologic Cancer

Autor Domchek, Susan M., Robson, Mark E.
Vydáno v J Clin Oncol (2019)

Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing

Autor Bradbury, Angela R., Patrick-Miller, Linda, Domchek, Susan
Vydáno v Genet Med (2014)

Immunotherapy for breast cancer: what are we missing?

Autor Vonderheide, Robert H., Domchek, Susan M., Clark, Amy S.
Vydáno v Clin Cancer Res (2017)

Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers

Autor Tai, Yu Chuan, Domchek, Susan, Parmigiani, Giovanni, Chen, Sining
Vydáno 2007

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

Autor Rebbeck, Timothy R., Kauff, Noah D., Domchek, Susan M.
Vydáno 2009

Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis

Autor Friebel, Tara M., Domchek, Susan M., Rebbeck, Timothy R.
Vydáno 2014

Ethical Implications of Direct-to-Consumer Hereditary Cancer Tests

Autor Kilbride, Madison K., Domchek, Susan M., Bradbury, Angela R.
Vydáno v JAMA Oncol (2018)

Reply to Patel and McLeod

Autor Kilbride, Madison K., Domchek, Susan M., Bradbury, Angela R.
Vydáno v J Clin Oncol (2019)

How Should Patients and Providers Interpret the US Food and Drug Administration’s Regulatory Language for Direct-to-Consumer Genetic Tests?

Autor Kilbride, Madison K., Domchek, Susan M., Bradbury, Angela R.
Vydáno v J Clin Oncol (2019)

CDH1 on Multigene Panel Testing: Look Before You Leap

Autor Katona, Bryson W, Clark, Dana Farengo, Domchek, Susan M
Vydáno v J Natl Cancer Inst (2019)

RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

Autor Chai, Xinglei, Domchek, Susan, Kauff, Noah, Rebbeck, Timothy, Chen, Jinbo
Vydáno v J Natl Cancer Inst (2015)

Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations

Autor Hannan, Zain, Yu, Shun, Domchek, Susan, Mamtani, Ronac, Reiss, Kim A
Vydáno v JNCI Cancer Spectr (2021)

RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis

Autor Katona, Bryson W, Stadler, Zsofia K, Robson, Mark E, Domchek, Susan M
Vydáno v J Natl Cancer Inst (2019)

Anti-Mullerian Hormone Levels are Lower in BRCA2 Mutation Carriers

Autor Johnson, Lauren, Sammel, Mary D., Domchek, Susan, Schanne, Allison, Prewitt, Maureen, Gracia, Clarisa
Vydáno v Fertil Steril (2017)

Utilization of Religious Coping Strategies Among African American Women at Increased Risk for Hereditary Breast and Ovarian Cancer

Autor Weathers, Benita, Kessler, Lisa, Collier, Aliya, Stopfer, Jill E., Domchek, Susan, Halbert, Chanita Hughes
Vydáno 2009

How Genetic Variant Libraries Effectively Extend Gene Testing Patents: Implications for Intellectual Property and Good Clinical Care

Autor McElligott, Sean, Field, Robert I., Bristol-Demeter, Mirar, Domchek, Susan M., Asch, David A.
Vydáno 2012